Little things that help. #ESMO4Carers ⁦ESMO - Eur. Oncology⁩

MO in #PDAC at #ESMO24  (1/2) Randomised pase II; 120 pts 2nd line NalIri + S-1 vs NalIri + 5-FU No differences in PFS (1ry end-point) Trend towars longer OS in the 5FU arm ESMO - Eur. Oncology #ESMOAmbassadors Grupo Español de Tratamiento de Tumores Digestivos Very nice diacussion by Arndt Vogel

MO in #PDAC at #ESMO24 (2/2) Phase II trial; 63 pts Maintenance Pembro+Olaparib in 3 selected cohorts of patients 1 – HRD 2 – ncHRD 3 –exceptional platinum responders Promising activity seen (1 > 2 > 3) Discussion by Arndt Vogel 👏🏻 ESMO - Eur. Oncology #ESMOAmbassadors Grupo Español de Tratamiento de Tumores Digestivos

Congratulations to #BestPosterPrize winning poster on #HCC in ESMO - Eur. Oncology #ESMO24 👉New targets coming to HCC 🥳 👏🏻👏🏻 Arndt Vogel #ESMOAmbassadors

Congratulations to #BestPosterPrize winning poster on #BiliaryCancer in ESMO - Eur. Oncology #ESMO24 👉New combinations to be tested, preliminary data promising 🤞🏻 👏🏻👏🏻 Arndt Vogel #ESMOAmbassadors

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors | New England Journal of Medicine nejm.org/doi/full/10.10… Directly from ESMO - Eur. Oncology to NEJM 🙌🏼🙌🏼

Great panel to discuss a difficult topic in #HCC in ESMO - Eur. Oncology #ESMO24 #Adjuvant and #Neoadjuvant 💪 Fantastic lectures and a packed room!! - (watch on demand if you missed it😉) Thanks all Lorenza Rimassa Anna Saborowski #BrunoSangeo #TimMeyer 👏🏻👏🏻 #ESMOAmbassadors

#Presidential Symposium III: #Eyes to the #Future at #ESMO24 👁️🔮 (1/2) 1️⃣ROME trial - targeted therapy vs SOC 2️⃣GigaPath - AI to predict genomic alterations 3️⃣4️⃣NO-CUT trial - multiomics and multidisciplinarity in oncology 👉 organ preservation ESMO - Eur. Oncology #ESMOAmbassadors SEOM

#Presidential Symposium III: #Eyes to the #Future at #ESMO24 👁️🔮 (2/2) 1️⃣2️⃣PIONeeR trial - Resistance to iPD(L)1 3️⃣4️⃣MTAP loss - targeting epigenetics (also in #BiliaryCancers and #PDAC 😉) ESMO - Eur. Oncology #ESMOAmbassadors Asociación ATUVIBI AMMF Cholangiocarcinoma Foundation ACanPan

So great to catch up Jon Lim, MRCP PhD 🥰🥰

#ESMOAmbassadors: We are excited to mark the first anniversary of this initiative at #ESMO24. ✨ Thanking the #ESMOAmbassadors for their stellar reporting during a year in life of the #OncologyCommunity 👏 — stay tuned.

Last (ish) posts on #ESMO24 with a selection of #posters on #NETs ESMO - Eur. Oncology #ESMOAmbassadors

Last (ish) posts on #ESMO24 with a selection of #posters on #HCC ESMO - Eur. Oncology #ESMOAmbassadors

Last (ish) posts on #ESMO24 with a selection of #posters on #BiliaryMalignancies ESMO - Eur. Oncology #ESMOAmbassadors

Now yes, #ESMO24 is gone! And it was a huge success! Congrats to our scientific and educational chairs Rebecca Dent and #KarinJordan 👏🏻 Save the date for next year 👀 #ESMO2025 📍Berlin 🗓️17-21 October See you all there 😊 ESMO - Eur. Oncology #ESMOAmbassadors

#TooMore vuelve con las novedades que no te puedes perder de #ESMO2024🔥🎙️ La Angela Lamarca nos hace un resumen de las comunicaciones más importantes en hepatocarcinoma🩺🆕 🎧¡Escúchalo aquí!🎧 open.spotify.com/episode/2Q6xX1… #formación #comunicación #investigación

La semana pasada, en el Congreso Europeo de Oncología que se celebró en Barcelona, reacreditaron a nuestro instituto oncológico, OncoHealth, como Centro Integral Europeo de Oncología y Cuidados Paliativos